NetScientific PLC Appointment to the Board (6157P)
14 Octubre 2019 - 1:00AM
UK Regulatory
TIDMNSCI
RNS Number : 6157P
NetScientific PLC
14 October 2019
NetScientific plc
("NetScientific" or the "Company")
Appointment to the Board
London, UK - 14 October 2019 - NetScientific plc (AIM: NSCI),
the transatlantic healthcare IP commercialisation Group, is pleased
to announce that Dr. Ilian Iliev will join the Board with immediate
effect as a non-executive director.
Ilian founded EMV Capital Limited, a London-based international
VC investor, focused on B2B companies in industrial high-tech,
energy, smart cities, transportation and healthtech. The firm's
investment model is to de-risk technologically complex investments
through industrial partnerships with some of the world's leading
corporations, as well as attracting financial investors to its
portfolio companies. EMV Capital Limited is a spin-out from
EcoMachines Ventures Limited, which was founded by Ilian in
2013.
Ilian holds a PhD from Cambridge University's Judge Business
School, MCom in Economics and BA in Politics, Economics and
International Relations from the University of Witwatersrand. He is
also an Associate Fellow at Chatham House, focused on energy and
resource efficiency.
Dr. Ilian Petkov Iliev (aged 44) currently holds or has held in
the past 5 years the following directorships and partnerships:
Current directorships Past Directorships & Partnerships
EMV Capital Limited EcoMachines Ventures Limited
Q-Bot Limited Autorose Limited
Sofant Technologies Limited Power Drive Efficiency Limited
Pointgrab, Inc. (Israel) Recycling Technologies Limited
Wanda Health, Inc. (USA) Pulsar Capital Solutions
Limited
Vortex Biosciences, Inc. (USA) Rotary EcoMachines Limited
Cambridge Intellectual Property DiagnovIS Limited
Limited
Satipimpex (South Africa)
Zoom Growth Investments Limited
London Innovation Partners Limited
Deeptech Growth Investments
Limited
Futura Messis Group Limited
BusiPro O.O.D. (Bulgaria)
In addition, Dr Iliev was a director of Stratpol Advisory
Services Limited, which entered into a voluntary arrangement with
its creditors in February 2010. The deficit to creditors was
GBP22,231.98.
No further disclosure is required under Paragraph (g) to
Schedule Two of the AIM Rules for Companies.
Commenting on the appointment, Sir Richard Sykes, Executive
Chairman of NetScientific, said:
"We welcome Ilian to the board of NetScientific and look forward
to his contribution to the Board."
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800
Ian Postlethwaite, CEO / CFO
WHIreland (NOMAD, Financial Adviser Tel: +44 (0)20 7220 1666
and Broker)
Chris Fielding / Darshan Patel
MO PR ADVISORY (Press Contact) Tel: +44 (0)78 7644 4977
Mo Noonan
About NetScientific
NetScientific PLC is a transatlantic healthcare IP
commercialisation Group focused on technologies and companies that
have the potential to treat chronic disease and significantly
improve the health and well-being of people.
For more information, please visit the website at
www.NetScientific.net
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAUARKRKAARARA
(END) Dow Jones Newswires
October 14, 2019 02:00 ET (06:00 GMT)
Netscientific (LSE:NSCI)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Netscientific (LSE:NSCI)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024